161 related articles for article (PubMed ID: 34930820)
21. Cannabinoid CB
He XH; Jordan CJ; Vemuri K; Bi GH; Zhan J; Gardner EL; Makriyannis A; Wang YL; Xi ZX
Acta Pharmacol Sin; 2019 Mar; 40(3):365-373. PubMed ID: 29967454
[TBL] [Abstract][Full Text] [Related]
22. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
Fattore L; Cossu G; Martellotta CM; Fratta W
Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
[TBL] [Abstract][Full Text] [Related]
23. The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB
Struik D; Fadda P; Zara T; Zamberletti E; Rubino T; Parolaro D; Fratta W; Fattore L
Pharmacol Res; 2017 Jan; 115():209-217. PubMed ID: 27890818
[TBL] [Abstract][Full Text] [Related]
24. The GABA
Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M
Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse.
Vasiljevik T; Franks LN; Ford BM; Douglas JT; Prather PL; Fantegrossi WE; Prisinzano TE
J Med Chem; 2013 Jun; 56(11):4537-50. PubMed ID: 23631463
[TBL] [Abstract][Full Text] [Related]
26. Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution.
Nguyen T; German N; Decker AM; Langston TL; Gamage TF; Farquhar CE; Li JX; Wiley JL; Thomas BF; Zhang Y
J Med Chem; 2017 Sep; 60(17):7410-7424. PubMed ID: 28792219
[TBL] [Abstract][Full Text] [Related]
27. COX-2 Inhibition Antagonizes Intra-Accumbens 2-Arachidonoylglycerol-Mediated Reduction in Ethanol Self-Administration in Rats.
Pavon FJ; Polis I; Stouffer DG; Roberto M; Martin-Fardon R; Rodriguez de Fonseca F; Parsons LH; Serrano A
Alcohol Clin Exp Res; 2020 Nov; 44(11):2158-2165. PubMed ID: 32944989
[TBL] [Abstract][Full Text] [Related]
28. Enhanced AMPA receptor activity increases operant alcohol self-administration and cue-induced reinstatement.
Cannady R; Fisher KR; Durant B; Besheer J; Hodge CW
Addict Biol; 2013 Jan; 18(1):54-65. PubMed ID: 23126443
[TBL] [Abstract][Full Text] [Related]
29. The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence.
Colombo G; Orrù A; Lai P; Cabras C; Maccioni P; Rubio M; Gessa GL; Carai MA
Mol Neurobiol; 2007 Aug; 36(1):102-12. PubMed ID: 17952655
[TBL] [Abstract][Full Text] [Related]
30. CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats.
Rubio M; Fernández-Ruiz J; de Miguel R; Maestro B; Michael Walker J; Ramos JA
Neuropharmacology; 2008 May; 54(6):976-88. PubMed ID: 18371990
[TBL] [Abstract][Full Text] [Related]
31. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
Schindler CW; Redhi GH; Vemuri K; Makriyannis A; Le Foll B; Bergman J; Goldberg SR; Justinova Z
Neuropsychopharmacology; 2016 Aug; 41(9):2283-93. PubMed ID: 26888056
[TBL] [Abstract][Full Text] [Related]
32. Role of endocannabinoids and cannabinoid CB1 receptors in alcohol-related behaviors.
Hungund BL; Basavarajappa BS
Ann N Y Acad Sci; 2004 Oct; 1025():515-27. PubMed ID: 15542757
[TBL] [Abstract][Full Text] [Related]
33. The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.
López-Moreno JA; González-Cuevas G; Navarro M
Neurobiol Dis; 2007 Feb; 25(2):274-83. PubMed ID: 17067804
[TBL] [Abstract][Full Text] [Related]
34. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling.
Balla A; Dong B; Shilpa BM; Vemuri K; Makriyannis A; Pandey SC; Sershen H; Suckow RF; Vinod KY
Neuropharmacology; 2018 Mar; 131():200-208. PubMed ID: 29109060
[TBL] [Abstract][Full Text] [Related]
36. Blockade of the cannabinoid CB1 receptor and alcohol dependence: preclinical evidence and preliminary clinical data.
Maccioni P; Colombo G; Carai MA
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):55-9. PubMed ID: 20201816
[TBL] [Abstract][Full Text] [Related]
37. mGluR5 antagonism inhibits cocaine reinforcement and relapse by elevation of extracellular glutamate in the nucleus accumbens via a CB1 receptor mechanism.
Li X; Peng XQ; Jordan CJ; Li J; Bi GH; He Y; Yang HJ; Zhang HY; Gardner EL; Xi ZX
Sci Rep; 2018 Feb; 8(1):3686. PubMed ID: 29487381
[TBL] [Abstract][Full Text] [Related]
38. Cocaine-induced increases in motivation require 2-arachidonoylglycerol mobilization and CB1 receptor activation in the ventral tegmental area.
Engi SA; Beebe EJ; Ayvazian VM; Cruz FC; Cheer JF; Wenzel JM; Zlebnik NE
Neuropharmacology; 2021 Aug; 193():108625. PubMed ID: 34058192
[TBL] [Abstract][Full Text] [Related]
39. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.
Arnone M; Maruani J; Chaperon F; Thiébot MH; Poncelet M; Soubrié P; Le Fur G
Psychopharmacology (Berl); 1997 Jul; 132(1):104-6. PubMed ID: 9272766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]